LungÕ 2026 – Virtual Global Congress on Lung Oncology
ASTRIDE Bridges the Gap: Serplulimab Matches 32% Two-Year Survival in U.S. Patients with Small Cell Lung Cancer
Daniel Malarek and a Wish for Oncology: A Future Where Breakthroughs Reach Every Patient
Expert Discussion at COGC 2026: The Right First Investments in Precision Oncology
From TAILORx to OPTIMA: Genomic Testing Expands Chemotherapy De-escalation in Higher-Risk HR-Positive Breast Cancer
Perioperative Ivonescimab Shows Promising Pathological Responses in Resectable NSCLC: Phase II Trial Reports 70.1% MPR and 50.7% pCR
BeOne Medicines’ Zanubrutinib Combination Gains FDA Priority Review for First-Line Mantle Cell Lymphoma
London Global Cancer Week 2026: Highlights From November 2–4
The EORTC Lung Cancer Group Multidisciplinary Webinar on Clinical Trials in Stage III NSCLC is scheduled for December 17, 2025, at 18:00 CET. This free, open-to-all online event will feature experts from medical oncology, radiation oncology, and thoracic surgery who will explore and discuss the status of current as well as upcoming clinical trials focused […]
The SITC Webinar on Bispecifics and T cell Engagers: Practical Strategies for Recognizing and Managing Toxicities is a virtual, multi-stakeholder event scheduled for December 17, 2025, from 1:00 p.m. to 2:15 p.m. ET. The webinar will feature expert faculty, including Sid Devarakonda, MD, and Megan May, PharmD, to provide clinical insights into the use of […]
"Going Full TILt: challenges, successes, and coordination with administering TIL therapy" is an upcoming "Rx-cited: Clinical Conundrums" roundtable organized by the ASTCT Pharmacy SIG Research Subcommittee and New Practitioner Task Force, scheduled for Wednesday, December 17, 2025, from 2:00–3:00 PM CST. The session is designed to be an informal Q&A discussion focusing on the challenges, […]
The 2026 ASCO Gastrointestinal Cancers Symposium will take place from January 8–10, 2026, at Moscone West in San Francisco, CA, as well as online. This annual event gathers oncology professionals from around the world to explore the latest developments in GI cancer treatment, research, and patient care. Featuring cutting-edge scientific presentations and multidisciplinary discussions, the […]
The Highlights of ASH in North America is a two-day program offered by the American Society of Hematology (ASH) in multiple locations to explore and discuss the most influential and novel research presented at the latest ASH Annual Meeting. The program is designed to allow hematology leaders and experts to connect in person, learn how […]
The ANCO’s Medicare Regulations Update 2026 webinar on January 14, 2026, will provide a comprehensive overview of the latest Medicare changes affecting oncology services. Bobbi Buell, MBA, will cover updates to the Physician Fee Schedule, coding and billing, evaluation and management, and incentive programs, offering essential insights for clinicians and practice teams. Register here.
The SEER-MHOS 2026 Update: Your Guide to the New Data Linkage is a specialized technical webinar hosted by the National Cancer Institute (NCI) Division of Cancer Control and Population Sciences. Scheduled for January 15, 2026, this session is designed for health services researchers, epidemiologists, and oncology professionals interested in leveraging large-scale data to study cancer […]
The MASCC Webinar “ADCs and Mucositis: From Mechanism to Care” on January 15, 2026, at 8:00 PM UTC+4 will explore the therapeutic potential and toxicity of antibody-drug conjugates (ADCs), with a focus on the recognition, prevention, and management of ADC-induced oral mucositis. Expert speakers, including Prof. Paolo Bossi, Prof. Florian Scotté, Dr. Barbara Pistilli, Dr. […]
The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management, covering topics from diagnosis to treatment, based on current standards of care in a multidisciplinary setting. The preceptorship will take place from January 16–17, 2026, in Milan, Italy. The course is […]
The Cancer Immunotherapy Winter School, hosted by the Society for Immunotherapy of Cancer (SITC), is a hybrid program taking place in Boston and virtually from February 16–18, 2026, with the in-person meeting held at The Westin Copley Place, Boston. The school is tailored for early-to-mid career scientists and clinicians who are new to the field, […]
The 22nd Oncology Updates: Advanced and Controversies Conference, presented by The University of Texas MD Anderson Cancer Center, is an interactive, multidisciplinary forum held from Friday, January 16 to Monday, January 19, 2026, at the Steamboat Grand Hotel in Steamboat Springs, Colorado. The conference is designed to address the rapidly evolving complexities of solid tumor […]
The 2nd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care will be held from January 16 to 18, 2026, in Hollywood, Florida. This premier event brings together a diverse range of oncology professionals including medical oncologists, hematologists, radiation oncologists, and other healthcare providers to explore the latest developments in cancer diagnosis, treatment, and supportive […]
The UK Interdisciplinary Breast Cancer Symposium (UKIBCS) 2026 is a biennial scientific meeting scheduled for January 19–20, 2026, at the International Convention Centre (ICC) in Birmingham, United Kingdom. Organized through a collaboration between Breast Cancer Now, the British Oncology Pharmacy Association (BOPA), the Association of Breast Surgery (ABS), and KC Jones Conference and Events, the […]
The 2026 Multidisciplinary Head and Neck Cancers Symposium (MHNCS) will be held February 19–21, 2026, at the JW Marriott Desert Springs in Palm Desert, California. Co‑sponsored by ASTRO, ASCO, AHNS, and SITC, the symposium brings together experts in surgery, radiation, medical oncology, and immunotherapy to share the latest research, clinical advances, and best practices. Focused […]
The European Association for Cancer Research (EACR) conference, "Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy," is a Virtual Event scheduled for January 20-21, 2026. This conference explores a paradoxical and radically different approach to cancer therapy: instead of inhibiting the signals that drive cancer, it focuses on the deliberate hyper-activation of oncogenic […]
The Better Breathing Week 2026 is the 43rd annual accredited lung health conference presented by the Lung Health Foundation, scheduled to take place from January 20–24, 2026, both in-person at the Hyatt Regency in Toronto, Canada, and virtually. As one of Canada's leading respiratory medical conferences, it brings together healthcare professionals, researchers, policymakers, and patient […]
